MOHAPATRA SUBHRA has a total of 14 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are INST PASTEUR OF SHANGHAI CHINESE ACAD OF SCIENCES, KARL THEURER DR MED and YEBIO BIOENG CO LTD QINGDAO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Mohapatra Subhra | 14 |
#2 | Wang Chunyan | 8 |
#3 | Mohapatra Shyam S | 5 |
#4 | Davis Yvonne Kathleen | 2 |
#5 | Pledger W Jack | 2 |
#6 | Das Mahasweta | 2 |
#7 | Pledger Jack W | 1 |
#8 | Howell Mark Christian | 1 |
#9 | Leonardo Christopher Charles | 1 |
#10 | Mohapatra Shyam | 1 |
Publication | Filing date | Title |
---|---|---|
US2018338996A1 | Combination therapy for traumatic brain injury | |
US9434926B1 | Graphene hydrogel and methods of using the same | |
US9675714B1 | Graphene based theranostics for tumor targeted drug/gene delivery and imaging | |
US2013230496A1 | Graphene hydrogel and method for using the same | |
US2013224860A1 | Three-dimensional fibrous scaffolds for cell culture | |
US2013243867A1 | Micelle compositions and methods for their use | |
US2012270923A1 | Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer | |
US2013330384A1 | Molecularly imprinted polymers having affinity for natriuretic peptides | |
WO2006132675A2 | Xiap-targeted prostate cancer therapy |